JP6538704B2 - 分析物値の伝送及び連続的監視のためのシステム及び方法 - Google Patents
分析物値の伝送及び連続的監視のためのシステム及び方法 Download PDFInfo
- Publication number
- JP6538704B2 JP6538704B2 JP2016552472A JP2016552472A JP6538704B2 JP 6538704 B2 JP6538704 B2 JP 6538704B2 JP 2016552472 A JP2016552472 A JP 2016552472A JP 2016552472 A JP2016552472 A JP 2016552472A JP 6538704 B2 JP6538704 B2 JP 6538704B2
- Authority
- JP
- Japan
- Prior art keywords
- display device
- transceiver
- sensor system
- analyte
- analyte sensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012491 analyte Substances 0.000 title claims description 322
- 238000000034 method Methods 0.000 title claims description 140
- 230000005540 biological transmission Effects 0.000 title description 31
- 238000012544 monitoring process Methods 0.000 title description 9
- 230000006854 communication Effects 0.000 claims description 132
- 238000004891 communication Methods 0.000 claims description 127
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 67
- 239000008103 glucose Substances 0.000 claims description 67
- 230000015654 memory Effects 0.000 claims description 40
- 238000012806 monitoring device Methods 0.000 claims description 7
- 238000013475 authorization Methods 0.000 claims 1
- 230000008569 process Effects 0.000 description 66
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 44
- 230000007958 sleep Effects 0.000 description 23
- 102000004877 Insulin Human genes 0.000 description 22
- 108090001061 Insulin Proteins 0.000 description 22
- 229940125396 insulin Drugs 0.000 description 22
- 238000005259 measurement Methods 0.000 description 22
- 230000004044 response Effects 0.000 description 22
- 238000012545 processing Methods 0.000 description 15
- 230000006870 function Effects 0.000 description 13
- 238000010586 diagram Methods 0.000 description 11
- 230000001960 triggered effect Effects 0.000 description 11
- 238000012790 confirmation Methods 0.000 description 10
- 230000002218 hypoglycaemic effect Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000012384 transportation and delivery Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000000737 periodic effect Effects 0.000 description 6
- 208000013016 Hypoglycemia Diseases 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- -1 nitrous oxide Amyl nitrate Chemical compound 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 3
- DIVQKHQLANKJQO-UHFFFAOYSA-N 3-methoxytyramine Chemical compound COC1=CC(CCN)=CC=C1O DIVQKHQLANKJQO-UHFFFAOYSA-N 0.000 description 2
- DUUGKQCEGZLZNO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Chemical compound C1=C(O)C=C2C(CC(=O)O)=CNC2=C1 DUUGKQCEGZLZNO-UHFFFAOYSA-N 0.000 description 2
- 102000004452 Arginase Human genes 0.000 description 2
- 108700024123 Arginases Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
- 108010085686 Hemoglobin C Proteins 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 2
- 241000223960 Plasmodium falciparum Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 102000011923 Thyrotropin Human genes 0.000 description 2
- 108010061174 Thyrotropin Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960003920 cocaine Drugs 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- PAHGJZDQXIOYTH-UHFFFAOYSA-N pristanic acid Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O PAHGJZDQXIOYTH-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- VSWSDTLXDWESGZ-AWEZNQCLSA-N (2s)-3-[4-(4-hydroxyphenoxy)phenyl]-2-(iodoamino)propanoic acid Chemical compound C1=CC(C[C@@H](C(=O)O)NI)=CC=C1OC1=CC=C(O)C=C1 VSWSDTLXDWESGZ-AWEZNQCLSA-N 0.000 description 1
- RLCKHJSFHOZMDR-UHFFFAOYSA-N (3R, 7R, 11R)-1-Phytanoid acid Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)CC(O)=O RLCKHJSFHOZMDR-UHFFFAOYSA-N 0.000 description 1
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- UUEZOEBHFHYMGR-RNWHKREASA-N (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;3-(4-chlorophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1.C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC UUEZOEBHFHYMGR-RNWHKREASA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- QNJJECIHYZJXRL-UHFFFAOYSA-N 1-(2-chlorophenyl)-2-methylpropan-2-amine;hydrochloride Chemical compound Cl.CC(C)(N)CC1=CC=CC=C1Cl QNJJECIHYZJXRL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QNLDTXPVZPRSAM-UHFFFAOYSA-N 17146-95-1 Chemical compound CC(O)C(O)=O.C1C2=CC=C(O)C=C2C2(C)C(C)C1N(CC=C(C)C)CC2 QNLDTXPVZPRSAM-UHFFFAOYSA-N 0.000 description 1
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 description 1
- UYVVLXVBEQAATF-WAIVXGPNSA-N 1b-Hydroxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)C[C@@H](O)[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 UYVVLXVBEQAATF-WAIVXGPNSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- LCZBQMKVFQNSJR-UJPCIWJBSA-N 21-deoxycortisol Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)C[C@@H]2O LCZBQMKVFQNSJR-UJPCIWJBSA-N 0.000 description 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 1
- RLCKHJSFHOZMDR-PWCSWUJKSA-N 3,7R,11R,15-tetramethyl-hexadecanoic acid Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(C)CC(O)=O RLCKHJSFHOZMDR-PWCSWUJKSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- RVWZUOPFHTYIEO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Natural products C1=C(O)C=C2C(C(=O)O)=CNC2=C1 RVWZUOPFHTYIEO-UHFFFAOYSA-N 0.000 description 1
- 239000003310 5-hydroxyindoleacetic acid Substances 0.000 description 1
- 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
- 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
- 102100036664 Adenosine deaminase Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- 201000006935 Becker muscular dystrophy Diseases 0.000 description 1
- KZFBHCCLJSAHBQ-UHFFFAOYSA-N Benzoylecgonine Natural products CN1C2CCC1C(C(C2)OC(=C)c3ccccc3)C(=O)O KZFBHCCLJSAHBQ-UHFFFAOYSA-N 0.000 description 1
- 108010039206 Biotinidase Proteins 0.000 description 1
- 102100026044 Biotinidase Human genes 0.000 description 1
- JQJPBYFTQAANLE-UHFFFAOYSA-N Butyl nitrite Chemical compound CCCCON=O JQJPBYFTQAANLE-UHFFFAOYSA-N 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 108010033547 Carbonic Anhydrase I Proteins 0.000 description 1
- 102100025518 Carbonic anhydrase 1 Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 108010071840 Cytosol nonspecific dipeptidase Proteins 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical class OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- LHQIJBMDNUYRAM-AWFVSMACSA-N D-erythro-biopterin Chemical compound N1=C(N)NC(=O)C2=NC([C@H](O)[C@H](O)C)=CN=C21 LHQIJBMDNUYRAM-AWFVSMACSA-N 0.000 description 1
- VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- MCYUUUTUAAGOOT-UHFFFAOYSA-N Desethylchloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCNCC)=CC=NC2=C1 MCYUUUTUAAGOOT-UHFFFAOYSA-N 0.000 description 1
- 108010028196 Dihydropteridine Reductase Proteins 0.000 description 1
- 102100022317 Dihydropteridine reductase Human genes 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 102100029115 Fumarylacetoacetase Human genes 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 241000224467 Giardia intestinalis Species 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 108010007979 Glycocholic Acid Proteins 0.000 description 1
- FOHHNHSLJDZUGQ-VWLOTQADSA-N Halofantrine Chemical compound FC(F)(F)C1=CC=C2C([C@@H](O)CCN(CCCC)CCCC)=CC3=C(Cl)C=C(Cl)C=C3C2=C1 FOHHNHSLJDZUGQ-VWLOTQADSA-N 0.000 description 1
- 239000004866 Hashish Substances 0.000 description 1
- 108010085682 Hemoglobin A Proteins 0.000 description 1
- 102000007513 Hemoglobin A Human genes 0.000 description 1
- 108010068323 Hemoglobin E Proteins 0.000 description 1
- 108091005880 Hemoglobin F Proteins 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 102000016871 Hexosaminidase A Human genes 0.000 description 1
- 108010053317 Hexosaminidase A Proteins 0.000 description 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- 108010056651 Hydroxymethylbilane synthase Proteins 0.000 description 1
- DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
- 240000004759 Inga spectabilis Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- LHQIJBMDNUYRAM-UHFFFAOYSA-N L-erythro-Biopterin Natural products N1=C(N)NC(=O)C2=NC(C(O)C(O)C)=CN=C21 LHQIJBMDNUYRAM-UHFFFAOYSA-N 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000883511 Lophophora williamsii Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000940612 Medina Species 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 102100034391 Porphobilinogen deaminase Human genes 0.000 description 1
- CZWCKYRVOZZJNM-UHFFFAOYSA-N Prasterone sodium sulfate Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 CZWCKYRVOZZJNM-UHFFFAOYSA-N 0.000 description 1
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-O S-adenosyl-L-methionine Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H]([NH3+])C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-O 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010016797 Sickle Hemoglobin Proteins 0.000 description 1
- 229930192786 Sisomicin Natural products 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040860 Skin haemorrhages Diseases 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 description 1
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 1
- 102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 1
- 108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100021436 UDP-glucose 4-epimerase Human genes 0.000 description 1
- 108010075202 UDP-glucose 4-epimerase Proteins 0.000 description 1
- 108010058532 UTP-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- 102000006321 UTP-hexose-1-phosphate uridylyltransferase Human genes 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000711975 Vesicular stomatitis virus Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 102100039662 Xaa-Pro dipeptidase Human genes 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 108010063628 acarboxyprothrombin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 229940070021 anabolic steroids Drugs 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- ANFSNXAXVLRZCG-RSAXXLAASA-N benzphetamine hydrochloride Chemical compound [Cl-].C([C@H](C)[NH+](C)CC=1C=CC=CC=1)C1=CC=CC=C1 ANFSNXAXVLRZCG-RSAXXLAASA-N 0.000 description 1
- 208000005980 beta thalassemia Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 1
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- QMQBBUPJKANITL-MYXGOWFTSA-N dextropropoxyphene hydrochloride Chemical compound [H+].[Cl-].C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 QMQBBUPJKANITL-MYXGOWFTSA-N 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229940120144 didrex Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- HYPPXZBJBPSRLK-UHFFFAOYSA-N diphenoxylate Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 HYPPXZBJBPSRLK-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229960001188 diphtheria antitoxin Drugs 0.000 description 1
- QCHSEDTUUKDTIG-UHFFFAOYSA-L dipotassium clorazepate Chemical compound [OH-].[K+].[K+].C12=CC(Cl)=CC=C2NC(=O)C(C(=O)[O-])N=C1C1=CC=CC=C1 QCHSEDTUUKDTIG-UHFFFAOYSA-L 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- GVGYEFKIHJTNQZ-RFQIPJPRSA-N ecgonine benzoate Chemical compound O([C@@H]1[C@@H]([C@H]2CC[C@@H](C1)N2C)C(O)=O)C(=O)C1=CC=CC=C1 GVGYEFKIHJTNQZ-RFQIPJPRSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 108010022687 fumarylacetoacetase Proteins 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
- 239000000380 hallucinogen Substances 0.000 description 1
- 229960003242 halofantrine Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108010047389 hemoglobin D Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- JUMYIBMBTDDLNG-OJERSXHUSA-N hydron;methyl (2r)-2-phenyl-2-[(2r)-piperidin-2-yl]acetate;chloride Chemical compound Cl.C([C@@H]1[C@H](C(=O)OC)C=2C=CC=CC=2)CCCN1 JUMYIBMBTDDLNG-OJERSXHUSA-N 0.000 description 1
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940087973 lomotil Drugs 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960001962 mefloquine Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 1
- 230000001722 neurochemical effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 1
- 229960001639 penicillamine Drugs 0.000 description 1
- 229940011043 percocet Drugs 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 229950010883 phencyclidine Drugs 0.000 description 1
- OOBHFESNSZDWIU-UHFFFAOYSA-N phenmetrazine Chemical compound CC1NCCOC1C1=CC=CC=C1 OOBHFESNSZDWIU-UHFFFAOYSA-N 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000013439 planning Methods 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229950009829 prasterone sulfate Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 108010066823 proline dipeptidase Proteins 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940099204 ritalin Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 108010093322 s-formylglutathione hydrolase Proteins 0.000 description 1
- 102000028528 s-formylglutathione hydrolase Human genes 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 229960005456 sisomicin Drugs 0.000 description 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960004673 sulfadoxine Drugs 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940066690 talwin Drugs 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960005367 tetanus antitoxin Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940063648 tranxene Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940071950 tussionex Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940072690 valium Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
- FUTVBRXUIKZACV-UHFFFAOYSA-J zinc;3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoate Chemical compound [Zn+2].[N-]1C2=C(C)C(CCC([O-])=O)=C1C=C([N-]1)C(CCC([O-])=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 FUTVBRXUIKZACV-UHFFFAOYSA-J 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B7/00—Radio transmission systems, i.e. using radiation field
- H04B7/24—Radio transmission systems, i.e. using radiation field for communication between two or more posts
- H04B7/26—Radio transmission systems, i.e. using radiation field for communication between two or more posts at least one of which is mobile
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L67/00—Network arrangements or protocols for supporting network services or applications
- H04L67/01—Protocols
- H04L67/12—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q9/00—Arrangements in telecontrol or telemetry systems for selectively calling a substation from a main station, in which substation desired apparatus is selected for applying a control signal thereto or for obtaining measured values therefrom
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q9/00—Arrangements in telecontrol or telemetry systems for selectively calling a substation from a main station, in which substation desired apparatus is selected for applying a control signal thereto or for obtaining measured values therefrom
- H04Q9/14—Calling by using pulses
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/70—Services for machine-to-machine communication [M2M] or machine type communication [MTC]
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W76/00—Connection management
- H04W76/10—Connection setup
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W76/00—Connection management
- H04W76/10—Connection setup
- H04W76/14—Direct-mode setup
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W76/00—Connection management
- H04W76/30—Connection release
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W76/00—Connection management
- H04W76/30—Connection release
- H04W76/34—Selective release of ongoing connections
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2209/00—Arrangements in telecontrol or telemetry systems
- H04Q2209/40—Arrangements in telecontrol or telemetry systems using a wireless architecture
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2209/00—Arrangements in telecontrol or telemetry systems
- H04Q2209/50—Arrangements in telecontrol or telemetry systems using a mobile data collecting device, e.g. walk by or drive by
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
- Y02D30/00—Reducing energy consumption in communication networks
- Y02D30/70—Reducing energy consumption in communication networks in wireless communication networks
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Computing Systems (AREA)
- Primary Health Care (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Mobile Radio Communication Systems (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Telephone Function (AREA)
Description
出願データシートに特定されるありとあらゆる優先権の主張またはそれに対するあらゆる補正は、37 CFR 1.57の下に参照により本明細書に組み込まれる。本出願は、2013年11月7日に出願された米国仮出願第61/901,358号の利益を主張する。前述の出願は、参照によりその全体が本明細書に組み込まれ、本明細書において明示的に本明細書の一部をなす。
概要
警告
表示デバイス
例示的な構成
連続的センサ
最初のデータ接続プロセスを促進する
カスタムアプリケーションをサスペンド状態から回復させる
データ接続を確立するためのアドバタイズメント信号の数を最小化する
表示デバイス間の切り替え
10 センサ
12 センサ電子装置モジュール
100 連続的分析物監視システム
110 表示デバイス
112 タッチスクリーンディスプレイ
120 携帯電話
122 タッチスクリーンディスプレイ
130 モバイル表示デバイス
132 タッチスクリーンディスプレイ
140 スマートウォッチ
142 タッチスクリーンディスプレイ
208 接着パッド
214 載置ユニット
234 基部
236 接触部サブアセンブリ
238 接触部
310 センサ測定回路
312 分析物センサ
314 プロセッサ
316 トランシーバ
318 メモリ
320 RTC
320 リアルタイム時計
330 プロセッサ
332 ディスプレイ
334 メモリ
336 リアルタイム時計
338 トランシーバ
1000 無線データ通信システム
1010 分析物センサシステム
1012 センサ電子装置モジュール
1014 連続的グルコースセンサ
1020 表示デバイス
1050 デバイス
Claims (7)
- 分析物センサシステムと前記分析物センサシステムから無線で受信した分析物値を表示することができる複数の表示デバイスとの間の無線データ通信のための方法であって、
第1の一連のアドバタイズメント信号を伝送することと、
第1の表示デバイスから第1のデータ接続要求を受信することと、
前記第1の表示デバイスが、1つまたは複数の許可される表示デバイスを含む第1のリストに特定されることを判定するにあたり、
前記第1の表示デバイスとの第1のデータ接続を確立することと、
異なる表示デバイスを現在アクティブな表示デバイスとして特定する情報を第2のリストから読み出し、前記情報を前記第1の表示デバイスに伝送することと、
前記第1の表示デバイスが新たに選択されたアクティブな表示デバイスであることを示す第1の信号を、前記第1の表示デバイスから受信することと、
前記第1の表示デバイスが前記現在アクティブな表示デバイスであることを示すように前記第2のリストを変更することと、
前記第1の表示デバイスが前記第1のリストに特定されないことを判定するにあたり、
前記第1の表示デバイスからの前記第1のデータ接続要求を拒絶するために、接続要求を停止させる信号を前記第1の表示デバイスに伝送することと、を含む、前記方法。 - 分析物センサシステムであって、前記分析物センサシステムから無線で受信した分析物値を表示することができる複数の表示デバイスとの無線データ通信のために構成され、
分析物センサと、
許可される1つまたは複数の表示デバイスを特定する第1のリストを記憶するためのメモリと、
前記表示デバイスのトランシーバに無線信号を伝送し及び前記表示デバイスの前記トランシーバから前記無線信号を受信するように構成されるトランシーバと、
前記分析物センサ、前記メモリ、及び前記トランシーバに操作可能に連結されたプロセッサであって、
前記トランシーバに、第1の一連のアドバタイズメント信号を伝送させることと、
第1の表示デバイスから第1のデータ接続要求を受信することと、
前記第1の表示デバイスが前記第1のリストに特定されることを判定するにあたり、
前記第1の表示デバイスとの第1のデータ接続を確立することと、
異なる表示デバイスを現在アクティブな表示デバイスとして特定する情報を第2のリストから読み出し、前記情報を前記第1の表示デバイスに伝送することと、
前記第1の表示デバイスが新たに選択されたアクティブな表示デバイスであることを示す第1の信号を、前記第1の表示デバイスから受信することと、
前記第1の表示デバイスが前記現在アクティブな表示デバイスであることを示すように前記第2のリストを変更することと、
前記第1の表示デバイスが前記第1のリストに特定されないことを判定するにあたり、
前記第1の表示デバイスからの前記データ接続要求を拒絶するために、接続要求を停止させる信号を前記第1の表示デバイスに伝送することと、を行うように構成される、プロセッサと、を備える、分析物センサシステム。 - 前記分析物センサは、連続的グルコースセンサである、請求項2に記載の分析物センサシステム。
- 前記複数の表示デバイスは、カスタム分析物監視デバイス、または、モバイルデバイスまたはスマートウォッチを含む、請求項2または3に記載の分析物センサシステム。
- 前記無線データ通信は、短距離かつ低電力の無線通信プロトコルを用いる、請求項2または3に記載の分析物センサシステム。
- 前記プロセッサは、リンク層(LL)コントローラである、請求項2または3に記載の分析物センサシステム。
- 分析物値を前記第1の表示デバイスに伝送するように構成された、請求項6に記載の分析物センサシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361901358P | 2013-11-07 | 2013-11-07 | |
US61/901,358 | 2013-11-07 | ||
PCT/US2014/064169 WO2015069797A1 (en) | 2013-11-07 | 2014-11-05 | Systems and methods for transmitting and continuous monitoring of analyte values |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019105427A Division JP7170589B2 (ja) | 2013-11-07 | 2019-06-05 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017503619A JP2017503619A (ja) | 2017-02-02 |
JP2017503619A5 JP2017503619A5 (ja) | 2017-12-14 |
JP6538704B2 true JP6538704B2 (ja) | 2019-07-03 |
Family
ID=52001066
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016552472A Active JP6538704B2 (ja) | 2013-11-07 | 2014-11-05 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
JP2019105427A Active JP7170589B2 (ja) | 2013-11-07 | 2019-06-05 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
JP2021124448A Active JP7203917B2 (ja) | 2013-11-07 | 2021-07-29 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
JP2022202288A Active JP7556931B2 (ja) | 2013-11-07 | 2022-12-19 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019105427A Active JP7170589B2 (ja) | 2013-11-07 | 2019-06-05 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
JP2021124448A Active JP7203917B2 (ja) | 2013-11-07 | 2021-07-29 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
JP2022202288A Active JP7556931B2 (ja) | 2013-11-07 | 2022-12-19 | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
Country Status (7)
Country | Link |
---|---|
US (14) | US9974470B2 (ja) |
EP (2) | EP4050617A1 (ja) |
JP (4) | JP6538704B2 (ja) |
CN (3) | CN116170766A (ja) |
AU (6) | AU2014346795A1 (ja) |
CA (2) | CA3205443A1 (ja) |
WO (1) | WO2015069797A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7170589B2 (ja) | 2013-11-07 | 2022-11-14 | デックスコム・インコーポレーテッド | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US20150316908A1 (en) * | 2010-11-12 | 2015-11-05 | Mount Everest Technologies, Llc | Sensor system |
US9788354B2 (en) | 2013-03-14 | 2017-10-10 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
EP4220654A1 (en) | 2013-03-14 | 2023-08-02 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
US12115375B2 (en) | 2013-11-27 | 2024-10-15 | Pacesetter, Inc. | Medical device and method for managing advertisement period |
US11007370B2 (en) | 2013-11-27 | 2021-05-18 | Pacesetter, Inc. | System and methods for establishing a communication session between an implantable medical device and an external device |
CA2935938A1 (en) * | 2014-01-10 | 2015-07-16 | Ascensia Diabetes Care Holdings Ag | Setup synchronization apparatus and methods for end user medical devices |
US9767232B2 (en) | 2014-01-30 | 2017-09-19 | Schechter Tech, Llc | Temperature monitoring with simulated thermal buffer computed at a base station |
GB2535388B (en) * | 2014-02-10 | 2017-09-27 | Kit Jiun Chan Mark | System of living |
US11237152B2 (en) | 2014-04-11 | 2022-02-01 | Ascensia Diabetes Care Holdings Ag | Wireless transmitter adapters for battery-operated biosensor meters and methods of providing same |
US9642556B2 (en) * | 2014-06-27 | 2017-05-09 | Intel Corporation | Subcutaneously implantable sensor devices and associated systems and methods |
CN106797528B (zh) | 2014-07-07 | 2020-11-17 | 安晟信医疗科技控股公司 | 用于经改进的低能数据通信的方法和设备 |
EP3210137B1 (en) | 2014-10-22 | 2021-03-10 | Dexcom, Inc. | User interfaces for continuous glucose monitoring |
AU2016209318A1 (en) * | 2015-01-21 | 2017-04-20 | Dexcom, Inc. | Continuous glucose monitor communication with multiple display devices |
KR20160099942A (ko) * | 2015-02-13 | 2016-08-23 | (주) 비비비 | 자가 진단 기능을 갖는 체액 분석기 및 이를 포함하는 체액 분석 시스템 |
EP3259020B1 (en) | 2015-02-16 | 2020-11-11 | Newronika S.p.A. | Apparatus for treating neurological disorders |
US10230740B2 (en) * | 2015-04-21 | 2019-03-12 | Cujo LLC | Network security analysis for smart appliances |
US10135633B2 (en) * | 2015-04-21 | 2018-11-20 | Cujo LLC | Network security analysis for smart appliances |
JP6744329B2 (ja) | 2015-04-29 | 2020-08-19 | アセンシア・ディアベティス・ケア・ホールディングス・アーゲー | 位置ベースのワイヤレス糖尿病管理システム、方法、および装置 |
US9247322B1 (en) | 2015-05-29 | 2016-01-26 | Schechter Tech, Llc | Low-power user interface device for environmental monitoring system |
US9844676B2 (en) | 2015-08-27 | 2017-12-19 | Medtronic, Inc. | Systems, apparatus and methods facilitating communication between an implantable device and an external device |
US10297130B2 (en) * | 2015-10-25 | 2019-05-21 | Igor Friedman | System for indicating the presence of a child within a vehicle by sending a signal to a mobile device after a predetermined amount of time |
US10356045B2 (en) | 2015-12-18 | 2019-07-16 | Cujo LLC | Intercepting intra-network communication for smart appliance behavior analysis |
CA2994016A1 (en) * | 2015-12-28 | 2017-07-06 | Dexcom, Inc. | Intelligent wireless communications for continuous analyte monitoring |
US11375932B2 (en) | 2015-12-30 | 2022-07-05 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US9833628B2 (en) | 2016-01-29 | 2017-12-05 | Medtronic, Inc. | Facilitating integrity of telemetry connectivity between an implantable device and a remote device |
KR20170091395A (ko) * | 2016-02-01 | 2017-08-09 | 삼성전자주식회사 | 데이터를 처리 및 제공하는 전자 장치 및 그의 동작 방법 |
IL261594B (en) | 2016-03-29 | 2022-08-01 | Hoffmann La Roche | A method for operating a receiver to receive test material data, a receiver and a computer program product |
US10980941B2 (en) | 2016-03-31 | 2021-04-20 | Dexcom, Inc. | Methods for providing an alert or an alarm to a user of a mobile communications device |
EP4344170A3 (en) | 2016-03-31 | 2024-06-05 | DexCom, Inc. | Systems and methods for display device and sensor electronics unit communication |
WO2017192397A1 (en) * | 2016-05-02 | 2017-11-09 | Dexcom, Inc. | System and method for providing alerts optimized for a user |
CN105847412A (zh) * | 2016-05-10 | 2016-08-10 | 爱国者电子科技有限公司 | 数据传输方法、装置及系统 |
WO2017222937A1 (en) * | 2016-06-20 | 2017-12-28 | Senseonics, Incorporated | Communication between devices using a wireless communication protocol |
ES2712051T3 (es) * | 2016-06-23 | 2019-05-09 | Hoffmann La Roche | Procedimiento para una comunicación inalámbrica de datos entre un sistema de sensores y un receptor, un sistema para la comunicación inalámbrica de datos y un producto de programa informático |
EP4277322A3 (en) * | 2016-07-20 | 2024-01-24 | Dexcom, Inc. | System and method for wireless communication of glucose data |
CN108366740B (zh) * | 2016-08-08 | 2021-07-13 | 六确认有限公司 | 测量多个生物信息的便携式复合传感器装置及测量方法 |
US10650621B1 (en) | 2016-09-13 | 2020-05-12 | Iocurrents, Inc. | Interfacing with a vehicular controller area network |
US11044537B2 (en) * | 2016-10-18 | 2021-06-22 | Dexcom, Inc. | System and method for communication of analyte data |
US11032855B2 (en) | 2016-10-18 | 2021-06-08 | Dexcom, Inc. | System and method for communication of analyte data |
CN106777999A (zh) * | 2016-12-26 | 2017-05-31 | 上海联影医疗科技有限公司 | 图像处理方法、系统和装置 |
CN110574414B (zh) * | 2016-12-27 | 2023-04-04 | 株式会社电装 | 用于微定位传感器通信的系统和方法 |
DE102017100348A1 (de) * | 2017-01-10 | 2018-07-12 | Vega Grieshaber Kg | Feldgerät und Verfahren zur Bereitstellung von Broadcast-Informationen |
US10448831B2 (en) * | 2017-03-31 | 2019-10-22 | BraveHeart Wireless Inc. | Wearable sensor |
US20190014607A1 (en) * | 2017-07-04 | 2019-01-10 | Arkray, Inc. | Measuring Apparatus and Display Apparatus |
JP6891072B2 (ja) * | 2017-08-09 | 2021-06-18 | オムロンヘルスケア株式会社 | 情報処理装置、受信方法、およびプログラム |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
CN209606445U (zh) | 2017-10-24 | 2019-11-08 | 德克斯康公司 | 预连接分析物传感器 |
JP7293217B2 (ja) | 2017-10-30 | 2023-06-19 | デックスコム・インコーポレーテッド | 分析物データの無線通信のための糖尿病管理パートナインターフェース |
US10182336B1 (en) * | 2017-12-18 | 2019-01-15 | Pacesetter, Inc. | Low power advertisement schedule for implantable medical device and method |
JP7149069B2 (ja) * | 2017-12-26 | 2022-10-06 | 日本光電工業株式会社 | 携帯情報端末、センサ、生体情報管理方法、生体情報処理プログラム、およびコンピュータが読み取り可能な記憶媒体 |
CN111655128A (zh) | 2018-02-09 | 2020-09-11 | 德克斯康公司 | 用于决策支持的系统和方法 |
EP3753274A1 (en) * | 2018-02-12 | 2020-12-23 | Fell Technology AS | A system and method for combining a wireless device, such as a key or other device with a wireless kill switch |
IT201800002962A1 (it) | 2018-02-22 | 2019-08-22 | Newronika Srl | Apparato per il trattamento di disordini neurologici mediante elettrostimolazione e metodo di elaborazione del segnale neurologico raccolto da detto apparato |
US10388412B1 (en) * | 2018-03-29 | 2019-08-20 | Reciprocal Labs Corporation | Decreased latency wireless communication for use with medicament devices |
CN109567741A (zh) * | 2018-10-15 | 2019-04-05 | 广东宝莱特医用科技股份有限公司 | 一种监护仪屏幕布局方法及系统 |
US11318309B2 (en) | 2018-12-13 | 2022-05-03 | Newronika S.P.A. | Method and apparatus for treating Tourette Syndrome by brain stimulation |
US20200203012A1 (en) | 2018-12-19 | 2020-06-25 | Dexcom, Inc. | Intermittent monitoring |
US10785720B2 (en) | 2019-01-23 | 2020-09-22 | Pacesetter, Inc. | Medical device with control circuitry to improve communication quality |
DE102019203236A1 (de) * | 2019-03-11 | 2020-09-17 | Continental Automotive Gmbh | Anordnung und Verfahren zum Betreiben einer Remote-Applikation |
US11000759B2 (en) * | 2019-03-29 | 2021-05-11 | Valve Corporation | Game controller operable in bluetooth low energy (BLE) mode |
CA3142233A1 (en) * | 2019-05-29 | 2020-12-03 | Dexcom, Inc. | System and method for wireless communication of analyte data |
WO2020261220A1 (en) * | 2019-06-27 | 2020-12-30 | ResMed Pty Ltd | System and method for fleet management of portable oxygen concentrators |
US20230219889A1 (en) | 2020-05-19 | 2023-07-13 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
WO2022047411A1 (en) | 2020-08-31 | 2022-03-03 | Abbott Diabetes Care Inc. | Secured communications in medical monitoring systems |
US12061834B2 (en) * | 2022-05-16 | 2024-08-13 | Google Llc | Methods and systems for facilitating user participation in content engagement activities |
Family Cites Families (168)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1033506A (en) | 1910-10-29 | 1912-07-23 | Williams Patent Crusher & Pulv | Shredding-hammer. |
US6035105A (en) | 1996-01-02 | 2000-03-07 | Cisco Technology, Inc. | Multiple VLAN architecture system |
JP3463460B2 (ja) | 1996-05-20 | 2003-11-05 | ヤマハ株式会社 | データ伝送方式 |
US6177395B1 (en) | 1996-10-31 | 2001-01-23 | The Procter & Gamble Company | Carpet cleaning compositions and method for cleaning carpets |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US6081736A (en) | 1997-10-20 | 2000-06-27 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems adapted for long term use |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
SG118132A1 (en) * | 1997-11-13 | 2006-01-27 | Hyperspace Communications Inc | File transfer system |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
ATE514372T1 (de) | 1998-10-08 | 2011-07-15 | Medtronic Minimed Inc | Kennzeichenmonitoringsystem mit fernmessung |
US6121817A (en) | 1999-01-11 | 2000-09-19 | Omnivision Technologies, Inc. | Analog median filter circuit for image processing |
US6424847B1 (en) | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
US6535980B1 (en) | 1999-06-21 | 2003-03-18 | International Business Machines Corporation | Keyless encryption of messages using challenge response |
US6347245B1 (en) | 1999-07-14 | 2002-02-12 | Medtronic, Inc. | Medical device ECG marker for use in compressed data system |
US6694191B2 (en) | 2000-01-21 | 2004-02-17 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method having telemetry modifiable control software |
US7369635B2 (en) | 2000-01-21 | 2008-05-06 | Medtronic Minimed, Inc. | Rapid discrimination preambles and methods for using the same |
JP3402468B2 (ja) * | 2000-08-24 | 2003-05-06 | 川崎製鉄株式会社 | 軸受の振動診断装置 |
US6915347B2 (en) | 2000-10-17 | 2005-07-05 | Sun Microsystems, Inc. | Associating multiple display units in a grouped server environment |
US8315563B2 (en) | 2000-12-22 | 2012-11-20 | Google Inc. | Wireless reader tags (WRTs) with sensor components in asset monitoring and tracking systems |
KR20020092420A (ko) | 2001-02-07 | 2002-12-11 | 마츠시타 덴끼 산교 가부시키가이샤 | 생체정보 처리시스템, 단말장치, 생체정보 처리장치,생체정보 처리방법 및 프로그램 |
US20020122410A1 (en) * | 2001-02-13 | 2002-09-05 | Cybiko Inc. | Method of wireless data exchange amongst devices of limited range |
US20040162035A1 (en) | 2001-03-08 | 2004-08-19 | Hannes Petersen | On line health monitoring |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
GB2385684A (en) | 2002-02-22 | 2003-08-27 | Sony Uk Ltd | Frequency synchronisation of clocks |
US6925586B1 (en) | 2002-05-09 | 2005-08-02 | Ronald Perrella | Methods and systems for centrally-controlled client-side filtering |
US20040068230A1 (en) | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US7282030B2 (en) | 2002-10-15 | 2007-10-16 | Medtronic, Inc. | Timed delay for redelivery of treatment therapy for a medical device system |
US20050038680A1 (en) | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
FI114126B (fi) | 2002-12-31 | 2004-08-13 | Vioteq Oy | Langattoman lähiverkon hallinta |
US7587287B2 (en) | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US20130059541A1 (en) | 2003-06-10 | 2013-03-07 | Abbott Diabetes Care Inc. | Wireless Communication Authentication for Medical Monitoring Device |
US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US8282549B2 (en) | 2003-12-09 | 2012-10-09 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US7460898B2 (en) | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7276029B2 (en) | 2003-08-01 | 2007-10-02 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20070208245A1 (en) | 2003-08-01 | 2007-09-06 | Brauker James H | Transcutaneous analyte sensor |
US8233959B2 (en) | 2003-08-22 | 2012-07-31 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
CN101341727B (zh) | 2003-09-26 | 2012-04-18 | 迪斯尼企业公司 | 父母控制的蜂窝电话 |
WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
EP1718198A4 (en) | 2004-02-17 | 2008-06-04 | Therasense Inc | METHOD AND SYSTEM FOR PROVIDING DATA COMMUNICATION IN A CONTINUOUS BLOOD SUGAR MONITORING AND MANAGEMENT SYSTEM |
US7406105B2 (en) | 2004-03-03 | 2008-07-29 | Alfred E. Mann Foundation For Scientific Research | System and method for sharing a common communication channel between multiple systems of implantable medical devices |
US7120750B1 (en) | 2004-04-16 | 2006-10-10 | Sun Microsystems, Inc. | Method and system for handling queue overflow during in-cache garbage collection |
US20070100222A1 (en) | 2004-06-14 | 2007-05-03 | Metronic Minimed, Inc. | Analyte sensing apparatus for hospital use |
US20060001538A1 (en) | 2004-06-30 | 2006-01-05 | Ulrich Kraft | Methods of monitoring the concentration of an analyte |
US8886272B2 (en) | 2004-07-13 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US9044199B2 (en) | 2004-07-13 | 2015-06-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7369634B2 (en) | 2004-09-07 | 2008-05-06 | Intel Corporation | Training pattern for a biased clock recovery tracking loop |
EP1635508A1 (en) | 2004-09-08 | 2006-03-15 | Koninklijke Philips Electronics N.V. | Secure pairing for wireless communications devices |
EP1827207A2 (en) | 2004-10-04 | 2007-09-05 | Cyberkinetics Neurotechnology Systems, Inc. | Biological interface system |
US7697967B2 (en) * | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
KR100641979B1 (ko) | 2004-12-30 | 2006-11-02 | 동부일렉트로닉스 주식회사 | 반도체 소자의 금속 배선 형성 방법 |
US20060166629A1 (en) | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
US7547281B2 (en) | 2005-02-01 | 2009-06-16 | Medtronic Minimed, Inc. | Algorithm sensor augmented bolus estimator for semi-closed loop infusion system |
US8258923B2 (en) | 2005-03-14 | 2012-09-04 | Alfred E. Mann Foundation For Scientific Research | System and method for locating objects and communicating with the same |
WO2006100675A2 (en) | 2005-03-21 | 2006-09-28 | Neurotrax Corporation | Neurosurgical candidate selection tool |
US7561559B2 (en) | 2005-03-30 | 2009-07-14 | Ixia | Hardware time stamping and processor synchronization |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7595723B2 (en) | 2005-11-14 | 2009-09-29 | Edwards Lifesciences Corporation | Wireless communication protocol for a medical sensor system |
US8340672B2 (en) | 2006-01-06 | 2012-12-25 | Proxense, Llc | Wireless network synchronization of cells and client devices on a network |
US7873573B2 (en) | 2006-03-30 | 2011-01-18 | Obopay, Inc. | Virtual pooled account for mobile banking |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US20070231846A1 (en) | 2006-04-03 | 2007-10-04 | Cosentino Daniel L | Glucose meter communication method and system |
US8073008B2 (en) | 2006-04-28 | 2011-12-06 | Medtronic Minimed, Inc. | Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network |
US20070253021A1 (en) | 2006-04-28 | 2007-11-01 | Medtronic Minimed, Inc. | Identification of devices in a medical device network and wireless data communication techniques utilizing device identifiers |
US20070258395A1 (en) | 2006-04-28 | 2007-11-08 | Medtronic Minimed, Inc. | Wireless data communication protocols for a medical device network |
JP4650570B2 (ja) | 2006-05-11 | 2011-03-16 | 日本電気株式会社 | 送信装置、制御プログラム、送信方法 |
JP4455537B2 (ja) | 2006-05-24 | 2010-04-21 | 日本電信電話株式会社 | 無線通信を介して測定データを収集するためのネットワークシステム |
US7949404B2 (en) | 2006-06-26 | 2011-05-24 | Medtronic, Inc. | Communications network for distributed sensing and therapy in biomedical applications |
US20090105571A1 (en) | 2006-06-30 | 2009-04-23 | Abbott Diabetes Care, Inc. | Method and System for Providing Data Communication in Data Management Systems |
US20080031208A1 (en) | 2006-08-04 | 2008-02-07 | Microsoft Corporation | Synchronization between wireless devices while saving power |
US8233456B1 (en) | 2006-10-16 | 2012-07-31 | Marvell International Ltd. | Power save mechanisms for dynamic ad-hoc networks |
US20080092638A1 (en) | 2006-10-19 | 2008-04-24 | Bayer Healthcare Llc | Wireless analyte monitoring system |
JP4881438B2 (ja) | 2007-01-17 | 2012-02-22 | パナソニック電工株式会社 | 無線式火災警報システム |
WO2008091683A2 (en) | 2007-01-25 | 2008-07-31 | Senior Vitals, Inc. | System and method for physiological data readings, transmission and presentation |
JP5145360B2 (ja) | 2007-02-13 | 2013-02-13 | エスケーテレコム株式会社 | 無線個人通信ネットワークでの効率的な住所割り当て方法及び無線近距離個人通信機器 |
US8121857B2 (en) * | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US20080249386A1 (en) | 2007-04-04 | 2008-10-09 | Pronia Medical Systems, Llc | Systems, Methods, and Computer Program Product for Improved Management of Medical Procedures for Patients on Medical Protocols |
US20080278332A1 (en) | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US20080300572A1 (en) | 2007-06-01 | 2008-12-04 | Medtronic Minimed, Inc. | Wireless monitor for a personal medical device system |
KR101391151B1 (ko) | 2007-06-01 | 2014-05-02 | 삼성전자주식회사 | 세션 키를 이용한 인증 방법 및 이를 위한 장치 |
US20080312518A1 (en) | 2007-06-14 | 2008-12-18 | Arkal Medical, Inc | On-demand analyte monitor and method of use |
AU2008265542B2 (en) | 2007-06-21 | 2014-07-24 | Abbott Diabetes Care Inc. | Health monitor |
EP3533387A3 (en) | 2007-06-21 | 2019-11-13 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US8085151B2 (en) | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
MX2009014275A (es) * | 2007-06-29 | 2010-04-27 | Hoffmann La Roche | Dispositivo y metodos para optimizar las comunicaciones entre un dispositivo medico y un dispsositivo electronico remoto. |
US8706145B2 (en) | 2007-07-10 | 2014-04-22 | Qualcomm Incorporated | Multihop paging of a peer in a peer-to-peer communication network |
US8077686B2 (en) | 2007-07-20 | 2011-12-13 | Marvell World Trade Ltd. | Multiple packet data network support over trusted access |
US7948833B2 (en) | 2007-07-25 | 2011-05-24 | Computime, Ltd. | Clock setup over a network |
US20090036760A1 (en) | 2007-07-31 | 2009-02-05 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in a medical communication system |
EP2182838B1 (en) | 2007-07-31 | 2016-05-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20090085768A1 (en) | 2007-10-02 | 2009-04-02 | Medtronic Minimed, Inc. | Glucose sensor transceiver |
US9167505B2 (en) | 2007-10-08 | 2015-10-20 | Qualcomm Incorporated | Access management for wireless communication |
US9949641B2 (en) | 2007-10-19 | 2018-04-24 | Smiths Medical Asd, Inc. | Method for establishing a telecommunications system for patient monitoring |
EP2252196A4 (en) | 2008-02-21 | 2013-05-15 | Dexcom Inc | SYSTEMS AND METHOD FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA |
US9402277B2 (en) | 2008-03-03 | 2016-07-26 | Qualcomm Incorporated | Proxy server for facilitating power conservation in wireless client terminals |
TWI455973B (zh) | 2008-03-05 | 2014-10-11 | Evonik Degussa Gmbh | 用於氣味控制的具有水楊酸鋅的超吸收性組合物 |
GB2458139A (en) | 2008-03-06 | 2009-09-09 | Toumaz Technology Ltd | Monitoring and tracking of wireless sensor devices in a healthcare monitoring system |
CN101247407B (zh) | 2008-03-17 | 2013-03-13 | 华为技术有限公司 | 网络认证服务系统和方法 |
US9241768B2 (en) | 2008-03-27 | 2016-01-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Intelligent input device controller for a robotic catheter system |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US20090300616A1 (en) | 2008-05-30 | 2009-12-03 | Abbott Diabetes Care, Inc. | Automated task execution for an analyte monitoring system |
CN101616495A (zh) * | 2008-06-23 | 2009-12-30 | 网秦无限(北京)科技有限公司 | 保护手机中个人隐私的方法及系统 |
MX2011002097A (es) | 2008-08-28 | 2011-08-03 | Isense Corp | Metodo y sistema de comunicacion entre dispositivos inalambricos. |
JP2010069193A (ja) | 2008-09-22 | 2010-04-02 | Panasonic Corp | 生体情報収集システム |
KR100994128B1 (ko) | 2008-09-23 | 2010-11-15 | 한국전자통신연구원 | 고정밀 네트워크 동기를 위한 타임 스탬핑 방법 및 장치 |
JP4649507B2 (ja) | 2008-09-24 | 2011-03-09 | 東芝テック株式会社 | 機器使用制限システム |
US20100082364A1 (en) | 2008-09-30 | 2010-04-01 | Abbott Diabetes Care, Inc. | Medical Information Management |
US8208973B2 (en) | 2008-11-05 | 2012-06-26 | Medtronic Minimed, Inc. | System and method for variable beacon timing with wireless devices |
US8938211B2 (en) * | 2008-12-22 | 2015-01-20 | Qualcomm Incorporated | Providing and utilizing maps in location determination based on RSSI and RTT data |
US8554615B2 (en) | 2009-02-24 | 2013-10-08 | Board Of Trustees Of Michigan State University | Context-induced wireless network transport for content and profile information |
US8635057B2 (en) | 2009-03-30 | 2014-01-21 | Microsoft Corporation | Enlightenment for low overhead hardware access |
WO2010121084A1 (en) | 2009-04-15 | 2010-10-21 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
WO2010127050A1 (en) | 2009-04-28 | 2010-11-04 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010127051A1 (en) | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
WO2010127187A1 (en) | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
EP3925533B1 (en) | 2009-04-30 | 2024-04-10 | DexCom, Inc. | Performance reports associated with continuous sensor data from multiple analysis time periods |
US8372351B2 (en) | 2009-05-29 | 2013-02-12 | Abbott Diabetes Care Inc. | Glucose monitoring system with wireless communications |
US20110009725A1 (en) | 2009-07-09 | 2011-01-13 | Medtronic Minimed, Inc. | Providing contextually relevant advertisements and e-commerce features in a personal medical device system |
US8260261B2 (en) | 2009-08-31 | 2012-09-04 | Qualcomm Incorporated | Securing pairing verification of devices with minimal user interfaces |
BR112012000220A2 (pt) | 2009-08-31 | 2020-12-22 | Abbott Diabetes Care Inc. | Métodos e dispositivos médicos |
WO2011029069A1 (en) | 2009-09-03 | 2011-03-10 | Human Touch, Llc | Comprehensive user control system for therapeutic wellness devices |
WO2011031891A1 (en) | 2009-09-09 | 2011-03-17 | Abbott Diabetes Care Inc. | Analyzing wireless communication degradation through comparison of communication links |
US9035744B2 (en) | 2009-10-01 | 2015-05-19 | Blackberry Limited | Method and apparatus for monitoring and controlling a medical device using a wireless mobile communication device |
WO2011063848A1 (en) | 2009-11-27 | 2011-06-03 | St. Jude Medical Ab | Methods for low power communication in an implantable medical device |
US8755269B2 (en) * | 2009-12-23 | 2014-06-17 | Medtronic Minimed, Inc. | Ranking and switching of wireless channels in a body area network of medical devices |
US8550997B2 (en) * | 2009-12-31 | 2013-10-08 | Medtronic Minimed, Inc. | Sensor and monitor system |
US20110184265A1 (en) | 2010-01-22 | 2011-07-28 | Abbott Diabetes Care Inc. | Method and Apparatus for Providing Notification in Analyte Monitoring Systems |
US8726266B2 (en) | 2010-05-24 | 2014-05-13 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
WO2011163519A2 (en) | 2010-06-25 | 2011-12-29 | Dexcom, Inc. | Systems and methods for communicating sensor data between communication devices |
US8938370B2 (en) | 2010-07-12 | 2015-01-20 | Advantest Corporation | Method and apparatus for complex time measurements |
WO2012010353A1 (en) | 2010-07-23 | 2012-01-26 | Abb Technology Ag | Method and arrangement for capacitor bank protection |
EP2621339B1 (en) | 2010-09-29 | 2020-01-15 | Dexcom, Inc. | Advanced continuous analyte monitoring system |
JP5875051B2 (ja) | 2010-11-08 | 2016-03-02 | 学校法人日本大学 | 認証サーバ及び認証サーバによる認証方法 |
US9094379B1 (en) * | 2010-12-29 | 2015-07-28 | Amazon Technologies, Inc. | Transparent client-side cryptography for network applications |
US8350338B2 (en) | 2011-02-08 | 2013-01-08 | International Business Machines Corporations | Semiconductor device including high field regions and related method |
WO2012108935A1 (en) | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Sensor-based informatics telemedicine disease management solution |
WO2012154286A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8839364B2 (en) | 2011-04-05 | 2014-09-16 | Blackberry Limited | System and method for applying authentication and security policies in a SIP environment |
US9002390B2 (en) * | 2011-04-08 | 2015-04-07 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
JP5878424B2 (ja) | 2011-04-28 | 2016-03-08 | アークレイ株式会社 | 試料測定装置および試料測定システム |
WO2013022775A1 (en) | 2011-08-05 | 2013-02-14 | Dexcom, Inc. | Systems and methods for detecting glucose level data patterns |
US9063775B2 (en) * | 2011-09-01 | 2015-06-23 | Microsoft Technology Licensing, Llc | Event aggregation for background work execution |
WO2013035902A1 (ko) | 2011-09-08 | 2013-03-14 | 엘지전자 주식회사 | 원격 건강 관리 솔루션에서 비디오를 기반으로 한 헬스 케어 시스템 및 헬스 케어 서비스 제공방법 |
EP3505065B1 (en) * | 2011-09-23 | 2021-03-03 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
CN103828479A (zh) | 2011-09-30 | 2014-05-28 | 英特尔公司 | 蓝牙通信的装置、系统和方法 |
US9151741B2 (en) * | 2011-11-02 | 2015-10-06 | Avery Dennison Corporation | RFID-based devices and methods for initializing a sensor |
US8738052B2 (en) | 2011-12-19 | 2014-05-27 | Motorola Solutions, Inc. | Method and apparatus for updating and using updated group aliases and incident IDs |
US8407759B1 (en) * | 2012-02-24 | 2013-03-26 | Monolith Innovations, LLC | Device, method, and system for secure mobile data storage |
IN2014DN09033A (ja) | 2012-04-03 | 2015-05-22 | Eclipse | |
US9092427B2 (en) | 2012-06-08 | 2015-07-28 | Lockheed Martin Corporation | Dynamic trust session |
US9788354B2 (en) | 2013-03-14 | 2017-10-10 | Dexcom, Inc. | Systems and methods for processing and transmitting sensor data |
CA3205443A1 (en) | 2013-11-07 | 2015-05-14 | Dexcom, Inc. | Systems and methods for transmitting and continuous monitoring of analyte values |
-
2014
- 2014-11-05 CA CA3205443A patent/CA3205443A1/en active Pending
- 2014-11-05 CN CN202211603113.1A patent/CN116170766A/zh active Pending
- 2014-11-05 CN CN201480060974.7A patent/CN105706423A/zh active Pending
- 2014-11-05 CN CN202010138849.0A patent/CN111314876B/zh active Active
- 2014-11-05 AU AU2014346795A patent/AU2014346795A1/en not_active Abandoned
- 2014-11-05 US US14/534,061 patent/US9974470B2/en active Active
- 2014-11-05 EP EP22153914.1A patent/EP4050617A1/en active Pending
- 2014-11-05 EP EP14805719.3A patent/EP3066600B1/en active Active
- 2014-11-05 CA CA2920308A patent/CA2920308C/en active Active
- 2014-11-05 US US14/534,054 patent/US9999379B2/en active Active
- 2014-11-05 WO PCT/US2014/064169 patent/WO2015069797A1/en active Application Filing
- 2014-11-05 US US14/534,057 patent/US10165967B2/en active Active
- 2014-11-05 JP JP2016552472A patent/JP6538704B2/ja active Active
- 2014-11-05 US US14/533,943 patent/US9974469B2/en active Active
-
2015
- 2015-12-08 US US14/962,370 patent/US10226205B2/en active Active
- 2015-12-08 US US14/962,330 patent/US9901292B2/en active Active
- 2015-12-08 US US14/962,907 patent/US20160089066A1/en not_active Abandoned
-
2017
- 2017-10-10 AU AU2017245326A patent/AU2017245326B2/en active Active
-
2018
- 2018-01-04 US US15/862,102 patent/US10335065B2/en active Active
- 2018-03-22 AU AU2018202050A patent/AU2018202050B2/en active Active
-
2019
- 2019-05-22 US US16/420,045 patent/US20190269356A1/en not_active Abandoned
- 2019-06-05 JP JP2019105427A patent/JP7170589B2/ja active Active
- 2019-10-29 AU AU2019257396A patent/AU2019257396A1/en not_active Abandoned
- 2019-11-25 US US16/694,900 patent/US10863931B2/en active Active
-
2020
- 2020-09-28 US US17/035,531 patent/US11399742B2/en active Active
-
2021
- 2021-07-26 AU AU2021209163A patent/AU2021209163B2/en active Active
- 2021-07-29 JP JP2021124448A patent/JP7203917B2/ja active Active
-
2022
- 2022-06-14 US US17/806,933 patent/US11730402B2/en active Active
- 2022-12-19 JP JP2022202288A patent/JP7556931B2/ja active Active
-
2023
- 2023-07-05 US US18/347,048 patent/US12070306B2/en active Active
- 2023-07-12 AU AU2023204617A patent/AU2023204617A1/en active Pending
-
2024
- 2024-07-08 US US18/766,495 patent/US20240358281A1/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7170589B2 (ja) | 2013-11-07 | 2022-11-14 | デックスコム・インコーポレーテッド | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7203917B2 (ja) | 分析物値の伝送及び連続的監視のためのシステム及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171106 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171106 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180822 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180910 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181210 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190507 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190606 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6538704 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |